Explore how evolving science, expanding global demand, and next-generation innovations are reshaping the future of corticosteroid and hormonal therapies — and what this transformation means for the years ahead.
INSIGHTS ON DRUG DEVELOPMENT
-
Is Industry Ready To Take A Bite Out Of Obesity?
What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?
-
A Novel Patient-Derived Colorectal Cancer Organoid Platform
Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.
-
Unlock Efficiency: Leverage The Right Tools To Build Process Knowledge
The biopharma industry must shift from data collection to process knowledge, leveraging digital tools to optimize drug development, enhance quality, and streamline tech transfer through digital maturity.
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
Reach Development Goals Faster With Multi-Sample Workflow Technology5/4/2024
Explore the use of Differential Scanning Calorimetry (DSC) multi-sample technology to analyze a variety of pharmaceutical materials and understand critical information for advancing pharma development.
-
Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development1/15/2026
Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.
-
This Is Where Quality Starts3/20/2026
Quality takes shape long before a workcell ships. Meet the people and processes that ensure consistent performance through every stage of development, and explore how to build reliability into each step.
-
Facts About AAV Producer Cell Lines8/8/2025
Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.
DRUG DEVELOPMENT SOLUTIONS
-
Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.
-
Understand and predict human response earlier in the drug development process, and harness the advantages of Organ-on-a-Chip technology without needing to invest in capital equipment or train personnel.
-
See More with Microflow LC-MS
The M5 MicroLC system is the perfect balance of sensitivity and robustness—more sensitive than traditional analytical flow LC, and more flexible and more robust than nanoflow LC — giving you the potential to optimize your critical workflows, today and into the future.
-
Overcome shared lab challenges with the Avanti JXN-30 high-speed centrifuge
- 4.0 L Max Capacity
- 30,000 RPM
- 110,510 x g
-
Explore immunoassays and LC-MS kits for over 30 clinical areas, each with detailed specifications and broad sample compatibility for precise, high-throughput biomarker analysis.